XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Net Loss per Share | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Net Loss per Share | NET LOSS PER SHARE Basic and diluted net loss per share attributable to common stockholders was calculated as follow:
| Three Months Ended March 31, |  |
(in thousands, except share and per share data) | 2024 |  | 2023 |  |  |  |
Numerator: |  |  |  |  |  |  |
Net loss | $ | (51,766) |  |  | $ | (24,020) |  |  |  |  |
Denominator: |  |  |  |  |  |  |
Weighted average shares of common stock outstanding—basic and diluted | 199,991,597 |  |  | 145,967,476 |  |  |  |  |
Net loss per share attributable to common stockholders— basic and diluted | $ | (0.26) |  |  | $ | (0.16) |  |  |  |  |
Basic and diluted weighted average shares of common stock outstanding for the three months ended March 31, 2024 and March 31, 2023 include the weighted average effect of outstanding pre-funded warrants for the purchase of shares of common stock for which the remaining unfunded exercise price is $0.01 or less per share. The Company’s potentially dilutive securities include outstanding stock options, unvested restricted stock units and warrants to purchase shares of common stock for the three months ended March 31, 2024 and 2023. All potentially dilutive securities have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share, and thus they are considered “anti-dilutive.” Therefore, the weighted average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential shares of common stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
| Three Months Ended March 31, |  |
| 2024 |  | 2023 |  |  |  |
Options to purchase shares of common stock | 8,082,838 |  |  | 2,830,300 |  |  |  |  |
Unvested restricted stock units | 8,371,586 |  |  | 5,835,016 |  |  |  |  |
Warrants to purchase shares of common stock (excluding prefunded warrants, which are included in basic shares outstanding) | 80,244,959 |  |  | 87,720,773 |  |  |  |  |
| 96,699,383 |  |  | 96,386,089 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration